In this study, we evaluate different manufacturing parameters for making an injectable biomaterial derived from skeletal muscle from pigs that has been stripped of all cells, leaving behind only the extracellular matrix of the tissue. We evaluate variability between animal sources, methods to reduce pathogen contamination, and methods of collecting the tissue. Multiple methods of analysis were used to evaluate appropriate conditions for manufacturing.